Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2025-12-25 @ 10:15 PM
Study NCT ID:
NCT01597258
Status:
COMPLETED
Last Update Posted:
2019-09-13
First Post:
2012-05-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05-29
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-16
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-10
First Submit QC Date:
None
Study First Post Date:
2012-05-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-15
Results First Submit QC Date:
None
Results First Post Date:
2019-09-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-12
Last Update Post Date:
2019-09-13
Last Update Post Date Type:
ACTUAL